Coppell Advisory Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-150	Closed	-$35.4K	–	384
2024 Q4	$35.4K	Buy	150 +11	+8%	+$2.6K	﹤0.01%	691
2024 Q3	$38.2K	Buy	+139	New	+$38.2K	0.01%	637
2023 Q4	$37.5K	Buy	+196	New	+$37.5K	0.01%	563